Outcomes studies and collaboration with academia will further the cause of in vitro diagnostics (IVD) industry
This article was originally published in Clinica
Executive Summary
Health economists and third parties paying for healthcare do not have a clue what the in vitro diagnostic industry is about. This is the message Eric Hornnaess of Abbott Diagnostics Division had for delegates at the annual meeting of the British In Vitro Diagnostics Association (BIVDA), reports Helen Gavaghan.